Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technology to address unmet medical needs, today ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Equity Offerings

Ascendis Pharma (ASND) Prices 4.166M ADS Offering at $120/ADSMarch 6, 2019 5:57 AM Ascendis Pharma A/S Announces Proposed Public Offering of ADSsMarch 4, 2019 4:00 PM